3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow RNS60: new trials by email Literature Review of RNS60 trials Research Report on RNS60
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy RNS60, Placebo - Stroke, Ischemic | Phase 2 | Completed | Revalesio Corporation | 83 | 2021-07-07 | 2026-01-12 |
| The Effect of RNS60 on ALS Biomarkers RNS60 - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | Mario Negri Institute for Pharmacological Research | 147 | 2017-05-30 | 2023-04-21 |
| Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge RNS60, Placebo - Asthma | Phase 2 | Completed | Revalesio Corporation | 30 | 2015-04-01 | 2016-12-09 |
Amyotrophic Lateral Sclerosis (1) · Asthma (1) · Ischemic Stroke (1)
Revalesio Corporation (2) · Mario Negri Institute for Pharmacological Research (1)
United States (2) · Italy (1) · United Kingdom (1)
Ettore Beghi, MD (1)